Pfizer Says Off-Label Marketing FCA Suit Falls Short

Law360, Los Angeles (January 16, 2013, 7:19 PM EST) -- Pfizer Inc. asked a Massachusetts federal court on Tuesday to dismiss a False Claims Act whistleblower suit alleging that it improperly promoted off-label use of a schizophrenia drug, saying that the plaintiffs have failed to show that the drugmaker actually defrauded federal health care programs.

In Tuesday's motion, Pfizer said that former employees Alex Booker and Edmund Hebron, who serve as relators in the 2010 suit filed on behalf of the U.S., 28 states and the District of Columbia, have now tried six times to craft...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.